AB Sciex to Drive Innovation in Separations Science with Combination of Eksigent Chromatography with Capillary Electrophoresis

  AB Sciex to Drive Innovation in Separations Science with Combination of
  Eksigent Chromatography with Capillary Electrophoresis from Beckman Coulter
  Life Sciences

Global leader in analytical technologies to offer broader range of solutions
to scientists for analyzing complex samples

Business Wire

FRAMINGHAM, Mass. -- July 10, 2013

AB Sciex Pte. Ltd., a global leader in analytical technologies, today
announced the combination of its chromatography business with the capillary
electrophoresis (CE) business from Beckman Coulter Life Sciences, an innovator
in life science research, to advance separations science. This move brings
together Beckman Coulter’s expertise in microscale separation with the
expertise in microfluidics of the Eksigent chromatography team of AB Sciex.

This combination includes the transition of personnel as well as CE
technologies and resources from Beckman Coulter Life Sciences to AB Sciex ‒
two leading life science companies that are both owned by Danaher Corporation,
a leader in science and technology. This new alignment will enable better
serving of customers while addressing analytical challenges with powerful
scientific strategies that take advantage of complementary technologies.

“We are bringing together the best in CE with the best in nano LC and micro LC
as a unified team to broaden the range of solutions available to our
customers,” said Rainer Blair, President of AB Sciex. “By integrating the
Beckman Coulter CE team into the Sciex separations business, we will be able
to take CE and our chromatography solutions to a whole new level. We are
committed to investing in our separations business for long-term success.”

The Eksigent LC team of the Sciex separations business and the CE team of
Beckman Coulter, a leader in benchtop capillary electrophoresis, will work
together going forward to develop breakthrough, integrated applications that
provide fast and efficient separations of drugs, drug metabolites, organic
acids, amino acids, low molecular weight amines, peptides, nucleic acids and

The new alignment within the Sciex separations business will also unlock
greater potential to extend technology leadership, synergies and market
presence. This will contribute to the advancement of biologics, clinical
research and academic research for biological applications.

Among the synergies is the combination of CE technology and mass spectrometry
(MS) technology. CE-MS allows researchers to expand the range of analytes
detected while improving overall assay sensitivity. The selectivity of CE in
front-end separation further enables the characterization of intact proteins,
their isoforms, cleaved fragments and complexes. CE-MS provides information
that is complementary to nano LC for proteomics research.

By the end of Q3, the Sciex separations business will manage both the
standalone Beckman Coulter CE products and the integrated CE-MS technology.
The CE products will continue to be branded ‘Beckman Coulter.’ The separations
business will also continue to manage all chromatography products, including
Eksigent nano LC and micro LC systems, chips, software and columns.

About Beckman Coulter Life Sciences

Beckman Coulter Life Sciences is dedicated to improving the health of people
around the world. The company’s global leadership and world-class service and
support delivers sophisticated instrument systems, reagents and services to
life science researchers in academic and commercial laboratories, enabling new
discoveries in biology-based research and development. A leader in
centrifugation and flow cytometry, Beckman Coulter has long been an innovator
in capillary electrophoresis, particle characterization and laboratory
automation, and its products are used at the forefront of important areas of
investigation, including genomics and proteomics. For more information, please
visit www.beckmancoulter.com.

About AB Sciex

AB Sciex helps to improve the world we live in by enabling scientists and
laboratory analysts to push the limits in their field and address the complex
analytical challenges they face. The company’s global leadership and
world-class service and support in the mass spectrometry industry have made it
a trusted partner to thousands of the scientists and lab analysts worldwide
who are focused on basic research, drug discovery and development, food and
environmental testing, forensics and clinical research. With 40 years of
proven innovation, AB Sciex excels by listening to and understanding the
ever-evolving needs of its customers to develop reliable, sensitive and
intuitive solutions that continue to redefine what is achievable in routine
and complex analysis. For more information about the company, go to

© 2013. AB Sciex. Unless otherwise noted in our product literature, AB Sciex
Products Are For Research Use Only. Not for use in Diagnostics Procedures. For
more information, refer to www.absciex.com/products. The trademarks mentioned
herein are the property of AB SciexPte. Ltd. or their respective owners. AB
SCIEX^TM is being used under license.

Beckman Coulter and the stylized logo are trademarks of Beckman Coulter, Inc.
and are registered with the USPTO.

Photos/Multimedia Gallery Available:



AB Sciex Media Contact
Anthony Petrucci, 1-508-383-7961
Public Relations
Beckman Coulter Life Sciences Media Contact
Hillary Hunter, 1-561-714-7826
Public Relations
Press spacebar to pause and continue. Press esc to stop.